μ-opioid agonist-induced activation of G-protein-coupled inwardly rectifying potassium current in rat periaqueductal gray neurons

被引:33
作者
Han, SH
Cho, YW
Kim, CJ
Min, BI
Rhee, JS
Akaike, N
机构
[1] Kyunghee Univ, Coll Med, Dept Physiol, Seoul 130701, South Korea
[2] Kyushu Univ, Fac Med, Dept Physiol, Higashi Ku, Fukuoka 81282, Japan
基金
新加坡国家研究基金会;
关键词
mu-opioid agonist; G-protein-coupled inwardly rectifying potassium current (GIRK); pertussis toxin-sensitive G-protein; second messenger system; periaqueductal gray neuron;
D O I
10.1016/S0306-4522(98)00409-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The characteristics of the inwardly rectifying K+ current activated by a mu-type opioid agonist, D-Ala(2),N-MePhe(4),Gly(5)-ol-enkephalin (DAMGO), were examined in the acutely dissociated rat periaqueductal gray neurons using the nystatin-perforated and the conventional whole-cell recording modes under voltage-clamp conditions. DAMGO activated inward currents in a concentration- and voltage-dependent manner. The DAMGO-induced current was an inwardly rectifying K+ current (I-DAMGO) which was sensitive to K+ channel blockers, quinine and Ba2+ but insensitive to Cs+ and tetraethylammonium. In the conventional whole-cell clamp mode, guanosine 5'-O-(2-thiodiphosphate) trilithium salt (GDP beta s, 0.4 mM) inhibited the amplitude of I-DAMGO to 28% Of that of the initial current. After the intracellular perfusion with guanosine 5'-O-(3-thiotriphosphate) tetralithium salt (GTP gamma s, 0.4 mM) for 1 min, the first application of DAMGO irreversibly activated I-DAMGO. By the extracellular application of N-ethylmaleimide at a concentration of 50 mu M for 2 min, I-DAMGO was completely abolished. When a conventional whole-cell patch was made with a patch-pipette containing 1 mu g/ml of pertussis toxin together with 1 mM of beta-nicotinamide adenine dinucleotide, I-DAMGO gradually declined to about 41% of its initial amplitude. The extracellular application of second messenger modulators including protein kinase inhibitor (staurosporin), protein kinase A activators (forskolin, 3-isobutyl-1-methyl-xanthine and dibutyryladenosine 3'5'-cyclic monophosphate) and protein kinase C activators (phorbol-12-myristale-13-acetate and 1-oleoyl-2-acetyl-sn-glycerol) had no effect on I-DAMGO. These results suggest that (i) DAMGO-activated inwardly rectifying K+ current is mediated by pertussis toxin-sensitive guanine nucleotide binding proteins (G-proteins); (ii) the types of G protein involved in I-DAMGO are G(i) and/or G(o); and (iii) the G-proteins exert their roles in I-DAMGO without any mediation of the second messenger systems. (C) 1999 IBRO. Published by Elsevier Science Ltd.
引用
收藏
页码:209 / 219
页数:11
相关论文
共 31 条
[1]   NYSTATIN PERFORATED-PATCH RECORDING AND ITS APPLICATIONS TO ANALYSES OF INTRACELLULAR MECHANISMS [J].
AKAIKE, N ;
HARATA, N .
JAPANESE JOURNAL OF PHYSIOLOGY, 1994, 44 (05) :433-473
[2]  
AKAIKE N, 1989, ACTA PHYSL SCAND S, V136, P582
[3]   ENDOGENOUS PAIN CONTROL-SYSTEMS - BRAIN-STEM SPINAL PATHWAYS AND ENDORPHIN CIRCUITRY [J].
BASBAUM, AI ;
FIELDS, HL .
ANNUAL REVIEW OF NEUROSCIENCE, 1984, 7 :309-338
[4]   Effects of serotonin on caudal raphe neurons: Activation of an inwardly rectifying potassium conductance [J].
Bayliss, DA ;
Li, YW ;
Talley, EM .
JOURNAL OF NEUROPHYSIOLOGY, 1997, 77 (03) :1349-1361
[5]   THE EFFECT OF [MET]ENKEPHALIN ON THE PERIAQUEDUCTAL GRAY NEURONS OF THE RAT - AN INVITRO STUDY [J].
BEHBEHANI, MM ;
JIANG, M ;
CHANDLER, SD .
NEUROSCIENCE, 1990, 38 (02) :373-380
[6]  
BROWN DA, 1990, ANNU REV PHYSIOL, V52, P215
[7]   HYPERPOLARIZATION BY OPIOIDS ACTING ON MU-RECEPTORS OF A SUBPOPULATION OF RAT PERIAQUEDUCTAL GRAY NEURONS IN-VITRO [J].
CHIENG, B ;
CHRISTIE, MJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (01) :121-128
[8]   ELECTROPHYSIOLOGY OF OPIOID-PEPTIDES AND SENSORY SYSTEMS [J].
DUGGAN, AW .
BRITISH MEDICAL BULLETIN, 1983, 39 (01) :65-70
[9]   NEUROTRANSMITTERS IN NOCICEPTIVE MODULATORY CIRCUITS [J].
FIELDS, HL ;
HEINRICHER, MM ;
MASON, P .
ANNUAL REVIEW OF NEUROSCIENCE, 1991, 14 :219-245
[10]  
GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151